Finding the acute treatment for chronic diseases.

Chronic Kidney Disease (CKD) affects around 13.4% of the worldwide population. According to the ESRD, CKD alone for free-of-care Medicare patients in 2013 cost $50.4 billion. It cost another $30.9 billion if End-Stage Renal Disease (ESRD) is taken into account. The global impact of kidney disease has been taking a toll on all healthcare systems for longer than anyone can remember. This needs to change.

At PharmaLegacy, we understand that your pipeline is the segway to future treatments. Our team of experts is at your disposal. Our validated CKD models developed by some of the industry’s most skilled and knowledgeable experts are ready to take your pipeline to the finish line. Should your pipeline require something novel, we stand ready to rapidly develop and validate new models and advance your therapies to the next stage.

Contact Us
Chronic Kidney Disease


Enforcing quality:

  • 1000+ validated animal models of disease spanning 40+ diseases
  • FDA Part 11 compliant
  • Rigorous adherence to international GLP and QA best practices
  • PK/PD, molecular pharmacology and preliminary toxicology adjacency studies

Entrust your pipeline to a CRO that strives for excellence. Entrust it to PharmaLegacy.

Contact Us

We’re ready when you are.

Tell us your pharmacology challenges.